Table 3.
Outcome measures | Group A | Group B | P (between groups) | |
---|---|---|---|---|
Mean±SD | Mean±SD | |||
VAS | Pre-treatment | 80.81±13.92 39.95±16.1** |
72.72±17.53 59.77±18.68** |
0.098 0.001* |
Post-treatment | ||||
TUG | Pre-treatment | 12.07±1.85 7.51±1.27** |
10.81±2.38 8.91±2.78** |
0.058 0.038* |
Post-treatment | ||||
WOMAC pain | Pre-treatment | 14.4±3.17 6.04±2.14** |
12.22±4.2 8.72±4.01** |
0.059 0.008* |
Post-treatment | ||||
WOMAC stiffness | Pre-treatment | 6.31±1.28 2.95±1.5** |
5.31±1.93 4.09±1.84** |
0.05 0.032* |
Post-treatment | ||||
WOMAC function | Pre-treatment | 45.45±9.43 19.95±7.22** |
44.54±9.21 32.77±10.91** |
0.748 0.0001* |
Post-treatment | ||||
WOMAC total | Pre-treatment | 66.45±12.03 28.95±8.69** |
61.63±13.36 46.04±15.35** |
0.216 0.0001* |
Post-treatment |
*Significance level is set at an alpha level of <0.05. SD: standard deviation. P: Probability value. **Statistically significant difference from the pre-treatment value for the same group